STOCK TITAN

Charlton Aria shareholder redemptions total $63.2M

The agreement requires at least $30,000,000 in aggregate cash at closing; $30,597,806 remained in trust after redemptions.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Charlton Aria Acquisition Corp. (CHAR) entered a business combination agreement with KQC Quantum, Inc. on October 6, 2026. Under the agreement, KQC MS Limited would merge into CHAR, which would survive as Parent’s wholly owned subsidiary, subject to the agreement’s conditions. The agreement assigns Parent an $80,000,000 equity value, provides for up to 1,500,000 earnout shares, and requires at least $30,000,000 in aggregate cash available at closing.

On October 19, shareholders approved up to 12 one-month extensions, through October 25, 2027. Holders of 5,725,962 public shares redeemed for approximately $11.03 per share, or $63,157,704 in aggregate. After the redemptions, 2,774,038 public shares remained outstanding and $30,597,806 remained in trust. Third-quarter net income was $138,124 versus $806,989 in 2025; nine-month net income was $1,405,762 versus $2,316,270.

As of September 30, 2026, cash was $30,962 and the working-capital deficit was $2,914,552. Management said these conditions raise substantial doubt about CHAR’s ability to continue as a going concern within one year after the financial statements are issued.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 2 points

How the balance works

Positive

  • None.

Negative

  • Major pointGoing-concern doubt: $30,962 cash and a $2,914,552 working-capital deficit as of September 30, 2026.
  • Minor pointQuarterly net income fell to $138,124 from $806,989 in 2025.

Filing Explained

The sponsor’s conversion reclassified shares; the converted shares receive no distribution from the trust account.

The proposed combination remains conditional: after quarter-end, Charlton Aria deposited $60,000 into trust on October 27, 2026, extending its deadline to November 25, 2026; KQC Quantum advanced $250,000 of deal costs on October 26, 2026, and the advance is not repayable.

On October 19, 2026, the sponsor converted 1,464,999 Class B ordinary shares into Class A shares one-for-one; following conversion and redemptions, 4,579,037 Class A and 660,001 Class B shares were outstanding, and the converted shares are not entitled to trust distributions.

To use another one-month extension, the sponsor or its designees must deposit $0.03 per remaining public share, capped at $60,000; each deposit is treated as a loan to Charlton Aria.

Third-quarter net income $138,124 Three months ended September 30, 2026; $806,989 for the same period in 2025
Nine-month net income $1,405,762 Nine months ended September 30, 2026; $2,316,270 for the same period in 2025
Cash $30,962 As of September 30, 2026
Working-capital deficit $2,914,552 As of September 30, 2026
Parent equity value $80,000,000 Value provided for Parent in the business combination agreement
Minimum aggregate cash available at closing $30,000,000 Business combination agreement condition
Public shares redeemed 5,725,962 shares In connection with the October 19, 2026 Extension Meeting
Aggregate redemption amount $63,157,704 Paid from the trust account in connection with the October 19, 2026 Extension Meeting
going concern financial
"substantial doubt about the Company’s ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
Working Capital Loans financial
"borrowings under the Working Capital Loans from the sponsor"
Working capital loans are short-term loans companies use to cover everyday operational expenses—such as payroll, inventory purchases, or utility bills—when incoming cash is delayed or uneven. Investors care because frequent or growing reliance on these loans can signal ongoing cash-flow stress and higher financial risk, while occasional use can simply smooth predictable ups and downs; like a household using a short-term loan to bridge paychecks, it affects a company’s short-term stability and flexibility.
temporary equity financial
"classified as temporary equity upon the completion of the IPO"
Equity-like securities that accounting rules require to be reported separately from permanent shareholders’ equity because the holder can force or the issuer is obligated to settle them in cash or other assets (or they will be settled on a specified date). Examples include mandatorily redeemable shares and certain convertible instruments with required cash settlement; on the balance sheet they appear between liabilities and shareholders’ equity (often called mezzanine or temporary equity) rather than as part of common equity.
earnout shares financial
"for up to 1,500,000 earnout shares"
Earnout shares are company stock promised to sellers as part of an acquisition that only becomes payable if the acquired business hits agreed future performance targets, like revenue or profit goals. They matter to investors because they can increase the number of shares outstanding (dilution), tie seller incentives to future success, and create uncertainty about the actual cost of the deal and future ownership unless the performance conditions are clearly understood.
De-SPAC Costs financial
"Parent is responsible for all De-SPAC Costs"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What conditions must CHAR meet to close its proposed business combination?

Closing is subject to satisfaction or waiver of conditions including CHAR shareholder approval, effectiveness of a Form S-4 registration statement, approval for listing on Nasdaq, and approval of an extension to CHAR’s business-combination deadline. Aggregate cash available at closing, including funds remaining in trust after redemptions and net proceeds from any private placement financing, must be at least $30,000,000.

How much does each CHAR deadline extension require?

For each one-month extension, the sponsor or one or more of its affiliates or designees must deposit $0.03 for each public share that remains outstanding, up to $60,000 per extension. Each deposit is treated as a loan to CHAR.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
00-0000000 http://fasb.org/srt/2026#ChiefExecutiveOfficerMember --12-31 0002024459 false Q3 0002024459 2026-07-01 2026-09-30 0002024459 us-gaap:SubsequentEventMember char:BusinessCombinationAgreementMember 2026-10-26 2026-10-26 0002024459 us-gaap:SubsequentEventMember char:TrustAccountMember 2026-10-27 2026-10-27 0002024459 us-gaap:SubsequentEventMember us-gaap:CommonClassBMember 2026-10-19 2026-10-19 0002024459 us-gaap:SubsequentEventMember us-gaap:CommonClassAMember 2026-10-19 2026-10-19 0002024459 us-gaap:SubsequentEventMember char:SponsorMember 2026-10-19 2026-10-19 0002024459 us-gaap:SubsequentEventMember 2026-10-19 2026-10-19 0002024459 us-gaap:SubsequentEventMember char:TrustAccountMember 2026-10-19 2026-10-19 0002024459 us-gaap:SubsequentEventMember char:TrustAccountMember 2026-10-19 0002024459 us-gaap:SubsequentEventMember 2026-10-08 2026-10-08 0002024459 us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2026-10-06 2026-10-06 0002024459 us-gaap:SubsequentEventMember char:BusinessCombinationAgreementMember 2026-10-06 0002024459 2026-01-01 2026-09-30 0002024459 char:SingleReportableSegmentMember 2025-01-01 2025-09-30 0002024459 char:SingleReportableSegmentMember 2026-01-01 2026-09-30 0002024459 char:SingleReportableSegmentMember 2025-07-01 2025-09-30 0002024459 char:SingleReportableSegmentMember 2026-07-01 2026-09-30 0002024459 char:PrivateRightsMember us-gaap:PrivatePlacementMember 2025-12-31 0002024459 char:PrivateRightsMember us-gaap:PrivatePlacementMember 2026-09-30 0002024459 char:PublicRightsMember us-gaap:PrivatePlacementMember 2025-12-31 0002024459 char:PublicRightsMember us-gaap:PrivatePlacementMember 2026-09-30 0002024459 char:FounderShares1Member char:ThreeIndependentDirectorsMember 2024-10-24 2024-10-24 0002024459 us-gaap:IPOMember char:FounderShares1Member 2024-10-24 2024-10-24 0002024459 char:FounderShares1Member char:MsMaMember 2024-09-11 2024-09-11 0002024459 char:FounderShares1Member char:MrGarnerMember 2024-09-11 2024-09-11 0002024459 char:FounderShares1Member 2024-09-11 2024-09-11 0002024459 us-gaap:CommonClassBMember 2025-12-31 0002024459 us-gaap:CommonClassBMember 2026-09-30 0002024459 us-gaap:IPOMember us-gaap:CommonClassBMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2026-01-01 2026-09-30 0002024459 us-gaap:CommonClassBMember char:SponsorMember 2024-04-01 2024-04-30 0002024459 us-gaap:CommonClassBMember 2024-04-30 0002024459 us-gaap:CommonClassBMember char:FounderShares1Member us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2024-04-30 0002024459 us-gaap:CommonClassBMember char:FounderShares1Member char:SponsorMember 2024-04-01 2024-04-30 0002024459 us-gaap:CommonClassBMember char:FounderShares1Member 2024-04-01 2024-04-30 0002024459 us-gaap:CommonClassAMember 2026-09-30 0002024459 us-gaap:CommonClassAMember 2025-12-31 0002024459 2026-09-30 0002024459 char:De-SPACCostFundingAgreementMember 2026-01-01 2026-09-30 0002024459 char:De-SPACCostFundingAgreementMember us-gaap:SubsequentEventMember 2026-10-06 2026-10-06 0002024459 char:De-SPACCostFundingAgreementMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2026-07-08 0002024459 char:BusinessCombinationAgreementMember 2026-07-08 2026-07-08 0002024459 char:UnderwritingAgreementMember 2025-12-31 0002024459 char:UnderwritingAgreementMember 2026-09-30 0002024459 char:UnderwritingAgreementMember 2026-01-01 2026-09-30 0002024459 us-gaap:CommonClassAMember char:UnderwritingAgreementMember 2026-09-30 0002024459 us-gaap:CommonClassAMember char:UnderwritingAgreementMember 2026-01-01 2026-09-30 0002024459 char:UnderwritingAgreementMember us-gaap:IPOMember 2026-01-01 2026-09-30 0002024459 char:UnderwritingAgreementMember 2024-11-19 2024-11-19 0002024459 us-gaap:OverAllotmentOptionMember char:UnderwritingAgreementMember 2026-01-01 2026-09-30 0002024459 us-gaap:OverAllotmentOptionMember 2026-01-01 2026-09-30 0002024459 char:SponsorMember char:WorkingCapitalLoansMember 2025-12-31 0002024459 char:SponsorMember char:WorkingCapitalLoansMember 2026-09-30 0002024459 char:SponsorMember char:WorkingCapitalLoansMember 2026-01-01 2026-09-30 0002024459 char:SponsorMember 2026-01-01 2026-09-30 0002024459 char:WorkingCapitalLoansMember 2026-04-24 0002024459 char:WorkingCapitalLoansMember 2026-04-24 2026-04-24 0002024459 char:WorkingCapitalLoansMember 2026-09-30 0002024459 char:SponsorMember char:WorkingCapitalLoansMember srt:MaximumMember 2026-09-30 0002024459 char:SponsorMember char:WorkingCapitalLoansMember 2026-08-25 2026-08-25 0002024459 char:SponsorMember 2026-04-17 2026-04-17 0002024459 2026-04-17 2026-04-17 0002024459 char:WorkingCapitalLoansMember 2026-01-01 2026-09-30 0002024459 char:PromissoryNoteMember 2024-04-18 0002024459 char:PromissoryNoteMember 2024-04-18 2024-04-18 0002024459 char:GeneralAccountingConsultingAgreementMember 2026-08-25 2026-08-25 0002024459 us-gaap:RelatedPartyMember char:Mr.PaulStricklandMember 2026-08-27 0002024459 us-gaap:RelatedPartyMember char:Mr.PaulStricklandMember 2026-09-30 0002024459 char:Mr.PaulStricklandMember char:One-TimePaymentMember 2026-09-30 0002024459 us-gaap:RelatedPartyMember char:Mr.PaulStricklandMember 2026-07-22 0002024459 char:MrJungMinLeeMember 2026-01-01 2026-09-30 0002024459 char:MrJungMinLeeMember 2026-03-26 0002024459 us-gaap:RelatedPartyMember char:MsYuanmeiMaMember 2026-09-30 0002024459 char:MsYuanmeiMaMember 2025-12-31 0002024459 char:MsYuanmeiMaMember 2026-09-30 0002024459 char:MsYuanmeiMaMember 2024-05-25 0002024459 us-gaap:RelatedPartyMember 2026-09-30 0002024459 char:MrWillGarnerMember 2025-01-01 2025-12-31 0002024459 char:MrWillGarnerMember 2026-01-01 2026-09-30 0002024459 char:MrWillGarnerMember 2024-06-14 0002024459 char:FounderShares1Member 2026-01-01 2026-09-30 0002024459 char:FounderShares1Member us-gaap:RelatedPartyMember 2026-09-30 0002024459 srt:DirectorMember 2024-10-24 0002024459 char:FounderShares1Member 2024-10-24 2024-10-24 0002024459 char:FounderShares1Member 2024-10-24 0002024459 char:FounderShares1Member srt:DirectorMember 2024-10-24 2024-10-24 0002024459 char:SponsorMember 2024-10-24 2024-10-24 0002024459 srt:OfficerMember 2024-09-11 0002024459 char:MsYuanmeiMaMember 2024-09-11 0002024459 char:MsYuanmeiMaMember 2024-09-11 2024-09-11 0002024459 char:FounderShares1Member char:MrWillGarnerMember 2024-09-11 2024-09-11 0002024459 us-gaap:IPOMember 2024-12-09 2024-12-09 0002024459 us-gaap:OverAllotmentOptionMember char:FounderShares1Member 2024-12-09 2024-12-09 0002024459 us-gaap:OverAllotmentOptionMember 2024-12-09 2024-12-09 0002024459 us-gaap:CommonClassBMember char:FounderShares1Member 2024-11-19 2024-11-19 0002024459 us-gaap:OverAllotmentOptionMember us-gaap:CommonClassBMember 2024-11-19 2024-11-19 0002024459 us-gaap:CommonClassBMember char:SponsorMember 2024-04-23 0002024459 us-gaap:CommonClassBMember char:SponsorMember 2024-04-23 2024-04-23 0002024459 us-gaap:CommonClassBMember char:FounderShares1Member 2024-04-23 0002024459 us-gaap:CommonClassBMember char:FounderShares1Member 2024-04-23 2024-04-23 0002024459 us-gaap:PrivatePlacementMember char:SponsorMember 2024-10-25 2024-10-25 0002024459 us-gaap:PrivatePlacementMember char:SponsorMember 2024-10-25 0002024459 us-gaap:IPOMember us-gaap:CommonClassAMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2024-11-19 2024-11-19 0002024459 us-gaap:IPOMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember us-gaap:RightsMember 2024-11-19 2024-11-19 0002024459 us-gaap:IPOMember us-gaap:CommonClassAMember 2024-11-19 0002024459 us-gaap:OverAllotmentOptionMember us-gaap:CommonClassAMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2024-11-19 2024-11-19 0002024459 us-gaap:IPOMember us-gaap:CommonClassAMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2024-10-25 2024-10-25 0002024459 char:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2026-09-30 0002024459 char:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2026-01-01 2026-09-30 0002024459 char:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2025-12-31 0002024459 char:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2025-01-01 2025-12-31 0002024459 char:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2024-12-31 0002024459 us-gaap:FairValueInputsLevel3Member char:MeasurementInputRightsMember 2026-09-30 0002024459 us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember us-gaap:FairValueInputsLevel3Member 2026-09-30 0002024459 us-gaap:FairValueInputsLevel3Member char:MeasurementInputInitialBusinessCombinationMember 2026-09-30 0002024459 us-gaap:MeasurementInputQuotedPriceMember us-gaap:FairValueInputsLevel3Member 2026-09-30 0002024459 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0002024459 us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0002024459 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-09-30 0002024459 us-gaap:FairValueMeasurementsRecurringMember 2026-09-30 0002024459 char:NonRedeemableClassAAndClassBOrdinarySharesMember 2025-01-01 2025-09-30 0002024459 char:RedeemableClassAOrdinarySharesMember 2025-01-01 2025-09-30 0002024459 char:NonRedeemableClassAAndClassBOrdinarySharesMember 2026-01-01 2026-09-30 0002024459 char:RedeemableClassAOrdinarySharesMember 2026-01-01 2026-09-30 0002024459 char:NonRedeemableClassAAndClassBOrdinarySharesMember 2025-07-01 2025-09-30 0002024459 char:RedeemableClassAOrdinarySharesMember 2025-07-01 2025-09-30 0002024459 char:NonRedeemableClassAAndClassBOrdinarySharesMember 2026-07-01 2026-09-30 0002024459 char:RedeemableClassAOrdinarySharesMember 2026-07-01 2026-09-30 0002024459 2025-07-01 2025-09-30 0002024459 2025-01-01 2025-09-30 0002024459 2025-12-31 0002024459 char:CharltonAriaAcquisitionCorporationMember 2026-09-30 0002024459 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember char:CharltonAriaAcquisitionCorporationMember 2026-09-30 0002024459 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember char:BusinessCombinationAgreementMember char:CharltonAriaAcquisitionCorporationMember 2026-09-30 0002024459 char:CharltonAriaAcquisitionCorporationMember 2026-01-01 2026-09-30 0002024459 us-gaap:IPOMember char:CharltonAriaAcquisitionCorporationMember 2026-01-01 2026-09-30 0002024459 char:CharltonAriaAcquisitionCorporationMember us-gaap:SubsequentEventMember 2026-10-01 0002024459 char:CharltonAriaAcquisitionCorporationMember 2026-08-03 0002024459 char:CharltonAriaAcquisitionCorporationMember 2026-04-24 0002024459 char:SponsorMember char:CharltonAriaAcquisitionCorporationMember 2026-01-01 2026-09-30 0002024459 us-gaap:OverAllotmentOptionMember char:CharltonAriaAcquisitionCorporationMember 2026-01-01 2026-09-30 0002024459 us-gaap:OverAllotmentOptionMember char:CharltonAriaAcquisitionCorporationMember 2026-09-30 0002024459 us-gaap:IPOMember char:CharltonAriaAcquisitionCorporationMember 2026-09-30 0002024459 us-gaap:IPOMember us-gaap:CommonClassAMember char:CharltonAriaAcquisitionCorporationMember 2026-01-01 2026-09-30 0002024459 us-gaap:IPOMember char:SponsorMember char:CharltonAriaAcquisitionCorporationMember 2026-01-01 2026-09-30 0002024459 us-gaap:CommonClassBMember char:SponsorMember char:CharltonAriaAcquisitionCorporationMember 2026-09-30 0002024459 us-gaap:CommonClassBMember char:SponsorMember char:CharltonAriaAcquisitionCorporationMember 2026-01-01 2026-09-30 0002024459 us-gaap:PrivatePlacementMember us-gaap:StockOptionMember char:CharltonAriaAcquisitionCorporationMember 2026-01-01 2026-09-30 0002024459 us-gaap:PrivatePlacementMember char:CharltonAriaAcquisitionCorporationMember 2024-11-19 0002024459 us-gaap:PrivatePlacementMember char:CharltonAriaAcquisitionCorporationMember 2024-11-19 2024-11-19 0002024459 us-gaap:PrivatePlacementMember char:SponsorMember char:CharltonAriaAcquisitionCorporationMember 2024-11-19 0002024459 us-gaap:OverAllotmentOptionMember char:CharltonAriaAcquisitionCorporationMember 2024-11-19 2024-11-19 0002024459 us-gaap:OverAllotmentOptionMember char:CharltonAriaAcquisitionCorporationMember 2024-10-25 2024-10-25 0002024459 us-gaap:PrivatePlacementMember char:SponsorMember char:CharltonAriaAcquisitionCorporationMember 2024-10-25 2024-10-25 0002024459 us-gaap:IPOMember char:CharltonAriaAcquisitionCorporationMember 2024-10-25 2024-10-25 0002024459 us-gaap:IPOMember char:CharltonAriaAcquisitionCorporationMember 2024-10-25 0002024459 us-gaap:IPOMember us-gaap:CommonClassAMember char:CharltonAriaAcquisitionCorporationMember 2024-10-25 2024-10-25 0002024459 us-gaap:IPOMember us-gaap:CommonClassAMember char:CharltonAriaAcquisitionCorporationMember 2024-10-25 0002024459 us-gaap:IPOMember us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember char:CharltonAriaAcquisitionCorporationMember 2024-10-25 2024-10-25 0002024459 2025-09-30 0002024459 2024-12-31 0002024459 us-gaap:RetainedEarningsMember 2025-09-30 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2025-09-30 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-09-30 0002024459 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0002024459 2025-06-30 0002024459 us-gaap:RetainedEarningsMember 2025-06-30 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2025-06-30 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-06-30 0002024459 2025-04-01 2025-06-30 0002024459 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0002024459 2025-03-31 0002024459 us-gaap:RetainedEarningsMember 2025-03-31 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2025-03-31 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-03-31 0002024459 2025-01-01 2025-03-31 0002024459 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0002024459 us-gaap:RetainedEarningsMember 2024-12-31 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2024-12-31 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2024-12-31 0002024459 us-gaap:RetainedEarningsMember 2026-09-30 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2026-09-30 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-09-30 0002024459 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0002024459 2026-06-30 0002024459 us-gaap:RetainedEarningsMember 2026-06-30 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2026-06-30 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-06-30 0002024459 2026-04-01 2026-06-30 0002024459 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0002024459 2026-03-31 0002024459 us-gaap:RetainedEarningsMember 2026-03-31 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2026-03-31 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-03-31 0002024459 2026-01-01 2026-03-31 0002024459 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0002024459 us-gaap:RetainedEarningsMember 2025-12-31 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2025-12-31 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-12-31 0002024459 us-gaap:CommonClassAMember 2025-01-01 2025-09-30 0002024459 us-gaap:CommonClassAMember 2026-01-01 2026-09-30 0002024459 us-gaap:CommonClassAMember 2025-07-01 2025-09-30 0002024459 us-gaap:CommonClassAMember 2026-07-01 2026-09-30 0002024459 us-gaap:RelatedPartyMember 2025-12-31 0002024459 us-gaap:CommonClassBMember 2026-10-22 0002024459 us-gaap:CommonClassAMember 2026-10-22 0002024459 char:RightsEachWholeRightToAcquireOneeighthOfOneClassAOrdinaryShareMember 2026-01-01 2026-09-30 0002024459 char:ClassAOrdinaryShares00001ParValueMember 2026-01-01 2026-09-30 0002024459 char:UnitsConsistingOfOneClassAOrdinaryShare00001ParValueAndOneRightToAcquireOneeighthOfOneClassAOrdinaryShareMember 2026-01-01 2026-09-30 0002024459 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0002024459 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-04-01 2026-06-30 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2026-04-01 2026-06-30 0002024459 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-04-01 2025-06-30 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2025-04-01 2025-06-30 0002024459 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0002024459 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-01-01 2026-03-31 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2026-01-01 2026-03-31 0002024459 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0002024459 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0002024459 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-01-01 2025-03-31 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2025-01-01 2025-03-31 0002024459 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0002024459 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0002024459 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-09-30 0002024459 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-09-30 0002024459 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0002024459 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-07-01 2026-09-30 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2026-07-01 2026-09-30 0002024459 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0002024459 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2025-07-01 2025-09-30 0002024459 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2025-07-01 2025-09-30 0002024459 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0002024459 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares char:Segment xbrli:pure

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________

 

Commission File Number: 001-42386

 

CHARLTON ARIA ACQUISITION CORPORATION

(Exact name of registrant as specified in its charter)

 

Cayman Islands   N/A
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

221 W 9th St, #848

Wilmington, Delaware 19801

(Address of principal executive offices and zip code)

 

(302) 319-3177

(Registrant’s telephone number, including area code)

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one right to acquire one-eighth of one Class A ordinary share   CHARU   The Nasdaq Stock Market LLC
Class A ordinary shares, $0.0001 par value   CHAR   The Nasdaq Stock Market LLC
Rights, each whole right to acquire one-eighth of one Class A ordinary share   CHARR   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
  Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

 

As of October 22, 2026, there were 4,579,037 Class A ordinary shares, par value $0.0001 per share, and 660,001 Class B ordinary shares, par value $0.0001 per share, of the registrant issued and outstanding.

 

 

 

 

 

 

TABLE OF CONTENTS

 

PART I. FINANCIAL INFORMATION 1
  Item 1. Financial Statements (Unaudited) 1
  Balance Sheets as of September 30, 2026 and December 31, 2025 (Unaudited) 1
  Statements of Operations for the Three and Nine Months Ended September 30, 2026 and 2025 (Unaudited) 2
  Statements of Changes in Shareholders’ Deficit for the Three and Nine Months Ended September 30, 2026 and 2025 (Unaudited) 3
  Statements of Cash Flows for the Nine Months Ended September 30, 2026 and 2025 (Unaudited) 5
  Notes to Unaudited Financial Statements 6
  Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 22
  Item 3. Quantitative and Qualitative Disclosures About Market Risk 29
  Item 4. Controls and Procedures 30
PART II. OTHER INFORMATION 31
  Item 1. Legal Proceedings 31
  Item 1A. Risk Factors 31
  Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 31
  Item 3. Defaults Upon Senior Securities 31
  Item 4. Mine Safety Disclosures 31
  Item 5. Other Information 31
  Item 6. Exhibits 32
Signatures 33

 

i 

 

 

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

 

CHARLTON ARIA ACQUISITION CORPORATION

BALANCE SHEETS

(Unaudited)

 

    September 30,
2026
    December 31,
2025
 
Assets            
Current assets            
Cash   $ 30,962     $ 5,135  
Prepaid expenses     27,322       8,156  
Total current assets     58,284       13,291  
Cash and investments held in trust account     93,579,630       89,444,533  
Total assets   $ 93,637,914     $ 89,457,824  
Liabilities, Class A ordinary shares subject to possible redemption and shareholders’ deficit                
Current liabilities                
Accounts payable and accrued expenses   $ 538,134     $ 33,877  
Due to related parties     52,823       63,750  
Working capital loans, related party     2,381,879       100,881  
Total current liabilities     2,972,836       198,508  
Deferred underwriting commission payable     1,700,000       1,700,000  
Total liabilities     4,672,836       1,898,508  
Commitments and contingencies (Note 6)                
Class A ordinary shares subject to possible redemption, 8,500,000 shares at redemption value of $11.01 and $10.52 per share as of September 30, 2026 and December 31, 2025, respectively     93,579,630       89,444,533  
Shareholders’ deficit                
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding     -       -  
Class A ordinary shares, $0.0001 par value; 445,000,000 shares authorized; 340,000 shares issued and outstanding (excluding 8,500,000 shares subject to possible redemption)     34       34  
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 2,125,000 shares issued and outstanding     213       213  
Additional paid-in capital     -       -  
Accumulated deficit     (4,614,799 )     (1,885,464 )
Total shareholders’ deficit     (4,614,552 )     (1,885,217 )
Total liabilities, Class A ordinary shares subject to possible redemption and shareholders’ deficit   $ 93,637,914     $ 89,457,824  

 

The accompanying notes are an integral part of these unaudited financial statements.

 

1 

 

 

CHARLTON ARIA ACQUISITION CORPORATION

STATEMENTS OF OPERATIONS

(Unaudited)

 

    Three Months
Ended
September 30,
2026
    Three Months
Ended
September 30,
2025
    Nine Months
Ended
September 30,
2026
    Nine Months
Ended
September 30,
2025
 
Formation and operating costs   $ 706,464     $ 109,077     $ 1,029,336     $ 406,709  
Loss from operations     (706,464 )     (109,077 )     (1,029,336 )     (406,709 )
Other income:                                
Interest and dividends earned on cash and investments held in trust account     844,588       915,972       2,435,097       2,719,802  
Interest income     -       94       1       3,177  
Total other income     844,588       916,066       2,435,098       2,722,979  
Net income   $ 138,124     $ 806,989     $ 1,405,762     $ 2,316,270  
Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption     8,500,000       8,500,000       8,500,000       8,500,000  
Basic and diluted net income per share, Class A ordinary shares subject to possible redemption   $ 0.01     $ 0.07     $ 0.13     $ 0.21  
Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B ordinary shares     2,465,000       2,465,000       2,465,000       2,465,000  
Basic and diluted net income per share, non-redeemable Class A and Class B ordinary shares   $ 0.01     $ 0.07     $ 0.13     $ 0.21  

 

The accompanying notes are an integral part of these unaudited financial statements.

 

2 

 

 

CHARLTON ARIA ACQUISITION CORPORATION

STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

For the Three and Nine Months Ended September 30, 2026 and 2025

(Unaudited)

 

For the Three and Nine Months Ended September 30, 2026

 

    Class A
Shares
    Class A
Amount
    Class B
Shares
    Class B
Amount
    Additional
Paid-in
Capital
    Accumulated
Deficit
    Total
Shareholders’
Deficit
 
Balance, December 31, 2025     340,000     $ 34       2,125,000     $ 213     $            -     $ (1,885,464 )   $ (1,885,217 )
Remeasurement of carrying value to redemption value     -            -       -       -       -       (786,480 )     (786,480 )
Net income     -       -       -       -       -       699,872       699,872  
Balance, March 31, 2026     340,000     $ 34       2,125,000     $ 213     $ -     $ (1,972,072 )   $ (1,971,825 )
Remeasurement of carrying value to redemption value     -       -       -       -       -       (804,029 )     (804,029 )
Extension deposit attributable to Class A ordinary shares subject to redemption     -       -       -       -       -       (850,000 )     (850,000 )
Net income     -       -       -       -       -       567,766       567,766  
Balance, June 30, 2026     340,000     $ 34       2,125,000     $ 213     $ -     $ (3,058,335 )   $ (3,058,088 )
Remeasurement of carrying value to redemption value     -       -       -       -       -       (844,588 )     (844,588 )
Extension deposit attributable to Class A ordinary shares subject to redemption     -       -       -       -       -       (850,000 )     (850,000 )
Net income     -       -       -       -       -       138,124       138,124  
Balance, September 30, 2026     340,000     $ 34       2,125,000     $ 213     $ -     $ (4,614,799 )   $ (4,614,552 )

 

The accompanying notes are an integral part of these unaudited financial statements.

 

3 

 

 

For the Three and Nine Months Ended September 30, 2025

 

    Class A
Shares
    Class A
Amount
    Class B
Shares
    Class B
Amount
    Additional
Paid-in
Capital
    Accumulated
Deficit
    Total
Shareholders’
Deficit
 
Balance, December 31, 2024     340,000     $ 34       2,125,000     $ 213     $         -     $ (1,293,097 )   $ (1,292,850 )
Remeasurement of carrying value to redemption value     -       -       -       -       -       (899,202 )     (899,202 )
Net income     -       -       -       -       -       731,257       731,257  
Balance, March 31, 2025     340,000     $ 34       2,125,000     $ 213     $ -     $ (1,461,042 )   $ (1,460,795 )
Remeasurement of carrying value to redemption value     -       -       -       -       -       (904,628 )     (904,628 )
Net income     -       -       -       -       -       778,024       778,024  
Balance, June 30, 2025     340,000     $ 34       2,125,000     $ 213     $ -     $ (1,587,646 )   $ (1,587,399 )
Remeasurement of carrying value to redemption value     -       -       -       -       -       (915,972 )     (915,972 )
Net income     -       -       -       -       -       806,989       806,989  
Balance, September 30, 2025     340,000     $ 34       2,125,000     $ 213     $ -     $ (1,696,629 )   $ (1,696,382 )

 

The accompanying notes are an integral part of these unaudited financial statements.

 

4 

 

 

CHARLTON ARIA ACQUISITION CORPORATION

STATEMENTS OF CASH FLOWS

(Unaudited)

 

    Nine Months
Ended
September 30,
2026
    Nine Months
Ended
September 30,
2025
 
Cash flows from operating activities:            
Net income   $ 1,405,762     $ 2,316,270  
Adjustments to reconcile net income to net cash used in operating activities:                
Interest and dividends earned on cash and investments held in trust account     (2,435,097 )     (2,719,802 )
Changes in operating assets and liabilities:                
Prepaid expenses     (19,166 )     (27,840 )
Accounts payable and accrued expenses     504,257       (17,772 )
Due to related parties     (10,927 )     12,500  
Net cash used in operating activities     (555,171 )     (436,644 )
Cash flows from investing activities:                
Extension deposits into trust account     (1,700,000 )     -  
Net cash used in investing activities     (1,700,000 )     -  
Cash flows from financing activities:                
Proceeds from working capital loans, related party     2,280,998       -  
Net cash provided by financing activities     2,280,998       -  
Net change in cash     25,827       (436,644 )
Cash, beginning of period     5,135       447,419  
Cash, end of period   $ 30,962     $ 10,775  
Supplemental disclosure of non-cash financing activities:                
Remeasurement of carrying value to redemption value   $ 2,435,097     $ 2,719,802  
Extension deposits attributable to Class A ordinary shares subject to possible redemption   $ 1,700,000     $ -  

 

The accompanying notes are an integral part of these unaudited financial statements.

 

5 

 

 

CHARLTON ARIA ACQUISITION CORPORATION

 

NOTES TO UNAUDITED FINANCIAL STATEMENTS

 

Note 1. Organization, Business Operation and Going Concern Consideration

 

Charlton Aria Acquisition Corporation (the “Company”) is a blank check company incorporated in the Cayman Islands on March 22, 2024 as an exempted company with limited liability. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination involving the Company, with one or more businesses or entities (the “initial business combination”). The Company’s efforts to identify a prospective target business will not be limited to a particular industry or geographic location. The Company has elected December 31 as its fiscal year end.

 

As of September 30, 2026, the Company had not commenced any operations. For the period from March 22, 2024 (inception) through September 30, 2026, the Company’s efforts have been limited to organizational activities as well as activities related to the initial public offering (the “IPO”) and the search for a target for a business combination. The Company will not generate any operating revenues until after the completion of an initial business combination, at the earliest. The Company will generate non-operating income in the form of dividend and/or interest income from the proceeds derived from the IPO and private placement (“Private Placement”, see Note 4).

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Placements Units (as defined below), although substantially all of the net proceeds are intended to be applied generally toward consummating an initial business combination. There is no assurance that the Company will be able to complete an initial business combination successfully.

 

The Company’s founder and sponsor is ST Sponsor II Limited, a Cayman Islands exempted company (the “sponsor”). The Company’s ability to commence operations is contingent upon obtaining adequate financial resources through IPO and the Private Placement.

 

On October 25, 2024, the Company consummated its initial public offering (the “IPO”) of 7,500,000 units (“Units”). Each Unit consists of one Class A ordinary share, $0.0001 par value per share, and one right to receive one-eighth of one Class A ordinary share upon the completion of the initial business combination. The Units were sold at an offering price of $10.00 per Unit, generating total gross proceeds of $75,000,000.

 

Simultaneously with the consummation of the IPO and the sale of the Units, the Company consummated the private placement (“Private Placement”) of 240,000 units (the “Private Placement Units”) to the sponsor, at a price of $10.00 per Private Placement Unit, generating total proceeds of $2,400,000, which is described in Note 4.

 

In connection with the IPO, the underwriters were granted an option to purchase up to 1,125,000 additional Units to cover over-allotments, if any (the “Over-allotment Option”). On November 19, 2024, the Representative exercised the Over-allotment Option in part, and purchased 1,000,000 Units (the “Option Units”), generating gross proceeds of $10,000,000. Simultaneously with the issuance and sale of the Option Units, the Company completed a private placement sale of 15,000 Private Placement Units (the “Additional Private Placement Units”) to the sponsor at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds of $150,000. The Company also issued an additional 10,000 Representative Shares (as defined below) to the Representative. The remaining Over-allotment Option expired on December 9, 2024.

 

6 

 

 

In connection with the offering of the Option Units and the sale of Additional Private Placement Units, the proceeds of $10,025,000 from the proceeds of the offering of the Option Units and the sale of Additional Private Placement Units were placed in the trust account established for the benefit of the Company’s public shareholders and the underwriters of the IPO, with Continental Stock Transfer & Trust Company acting as trustee.

 

31,250 shares of the 2,156,250 Class B ordinary shares, par value $0.0001 per share (“Class B ordinary share” or “founder shares”) (see Note 5) held by the sponsor were forfeited to the extent that the underwriters’ over-allotment option was exercised in part, so that the Company’s insiders would collectively own 20.0% of the Company’s issued and outstanding shares after the IPO (without giving effect to the sale of the Private Placement Units, the Representative Shares, and assuming the Company’s directors, officers, Sponsor or any of the foregoing’s affiliates (collectively, “insiders”) do not purchase Units in the IPO).

 

Transaction costs amounted to $3,408,558, consisting of $1,275,000 of underwriting commissions which was paid in cash at the closing date of the IPO, $1,700,000 of deferred underwriting commissions, $92,195 of the Representative Shares (discussed below), and $341,363 of other offering costs.

 

In conjunction with the IPO (including the partial exercise of the Over-allotment Option), the Company issued to the underwriter 85,000 Class A ordinary shares for no consideration (the “Representative Shares”). The fair value of the Representative Shares accounted for as compensation under Accounting Standards Codification (“ASC”) 718, “Compensation: Stock Compensation” (“ASC 718”) is included in the offering costs. The estimated fair value of the Representative Shares in connection with the IPO and the offering of the Option Units totaled $92,195.

 

The Company’s initial business combination must occur with one or more target businesses that together have an aggregate fair market value of at least 80% of the value of the trust account (excluding any deferred underwriters’ fees and taxes payable on the income earned on the trust account) at the time of the agreement to enter into the initial business combination. The Company will complete its initial business combination only if the post-transaction company in which its public shareholders own shares will own or acquire 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to complete an initial business combination successfully.

 

Upon the closing of the IPO, management has agreed that at least $10.025 per Unit sold in the IPO will be held into a U.S.-based trust account (“trust account”). The funds held in the trust account will be invested only in U.S. government treasury bills with a maturity of 185 days or less, or in money market funds meeting the applicable conditions of Rule 2a-7 promulgated under the Investment Company Act which invest solely in direct U.S. government treasury. Except with respect to dividend and/or interest earned on the funds held in the trust account that may be released to the Company to pay the Company’s tax obligation, if any, the proceeds from the IPO and the sale of the Private Placement Units that are deposited and held in the trust account will not be released from the trust account until the earliest to occur of (i) the completion of the Company’s initial business combination, (ii) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the company’s memorandum and articles of association effective at the time to (A) modify the substance or timing of obligation to redeem 100% of the Company’s public shares if the Company does not complete the Company’s initial business combination by the Combination Deadline (as defined below), or (B) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity and (iii) the redemption of all of public shares if the Company is unable to complete their initial business combination by the Combination Deadline, subject to applicable law. In no other circumstances will a public shareholder have any right or interest of any kind to or in the trust account. The proceeds deposited in the trust account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the public shareholders.

 

7 

 

 

The Company had until April 25, 2026 (or 18 months from the consummation of the IPO) to consummate its initial business combination. If it anticipates that it may not be able to consummate its initial business combination by then, it may, but is not obligated to, extend the period of time to consummate an initial business combination two times by an additional three months each time (until July 25, 2026 or October 25, 2026, or up to 21 months or 24 months from the consummation of the IPO to complete an initial business combination), provided that the sponsor and/or designees must deposit into the trust account for each three months extension, $850,000 ($0.10 per unit in either case), up to an aggregate of $1,700,000 on or prior to the date of the applicable deadline. The applicable deadline to consummate the initial business combination in each case, April 25, 2026, July 25, 2026, or October 25, 2026, is referred as the “Combination Deadline”. On April 24, 2026, the sponsor deposited $850,000 into the trust account, as a result of which, the Company had until July 25, 2026 to complete its initial business combination. On August 3, 2026, the sponsor deposited $850,000 into the trust account, as a result of which, the Company had until October 25, 2026 to complete its initial business combination. On October 6, 2026, the Company entered into a Business Combination Agreement with KQC Quantum, Inc. and the other parties thereto. On October 19, 2026, the Company’s shareholders approved amendments to the Company’s memorandum and articles of association and the Investment Management Trust Agreement that permit the Company to extend the Combination Deadline from October 25, 2026 up to twelve times, by one month each time, to as late as October 25, 2027. In connection with the extraordinary general meeting, holders of 5,725,962 public shares exercised their right to redeem their shares for approximately $11.03 per share (see Note 9). In October 2026, an aggregate of $60,000 was deposited into the Trust Account to extend the Business Combination Deadline to November 25, 2026.

 

The Company will provide its public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial business combination either (i) in connection with a shareholder meeting called to approve the initial business combination or (ii) by means of a tender offer.

 

The ordinary shares subject to redemption accreted to the redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Financial Accounting Standard Board’s (FASB) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” The Company has determined not to consummate any initial business combination unless the Company has net tangible assets of at least $5,000,001 upon such consummation in order to avoid being subject to Rule 419 promulgated under the Securities Act.

 

If the Company does not complete its initial business combination by Combination Deadline, the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account and not previously released to the Company to pay taxes that were paid by the Company or are payable by the Company, if any (less up to $100,000 of interest generated from the funds held in the trust account released to us to pay dissolution expenses) divided by the number of the then-issued and outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of its remaining shareholders and its board of directors, liquidate and dissolve, subject in each case to its obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. The sponsor and each member of management team have entered into an agreement with the Company, pursuant to which they have agreed to waive their rights to liquidating distributions from the trust account with respect to any founder shares they hold if the Company fails to consummate an initial business combination by the Combination Deadline.

 

8 

 

 

The sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or Business Combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.025 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.025 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of this offering against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked the sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Company’s sponsor has sufficient funds to satisfy its indemnity obligations and believes that the Sponsor’s only assets are securities of the company. Therefore, it cannot be assured that the sponsor would be able to satisfy those obligations. None of the officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.

 

Going Concern Consideration

 

As of September 30, 2026, the Company had $30,962 of cash and a working capital deficit of $2,914,552. The Company expects to incur significant professional costs to remain as a publicly traded company and to incur significant transaction costs in pursuit of the consummation of an initial business combination. In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the unaudited financial statements are issued. Management’s plan in addressing this uncertainty is through the Working Capital Loans, as defined below (see Note 5), and the funding of De-SPAC Costs by KQC Quantum, Inc. under Section 5.12 of the Business Combination Agreement (see Note 6). In addition, if the Company is unable to complete an initial business combination by the Combination Deadline, which may be extended month to month to as late as October 25, 2027 (see Note 9), the Company’s board of directors would proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company. There is no assurance that the Company’s plans to consummate an initial business combination will be successful within the Combination Deadline. As a result, management has determined that such additional condition also raises substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the unaudited financial statements are issued. The unaudited financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Risks and Uncertainties

 

As a result of the armed conflict involving the United States, Israel and Iran that began in February 2026, the ongoing military conflict between the Russian Federation and Ukraine, related economic sanctions, and changes in U.S. and international trade policies, including tariffs, the Company’s ability to consummate an initial business combination, or the operations of a target business with which the Company ultimately consummates an initial business combination, may be materially and adversely affected. In addition, the Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing, which may be impacted by these events, including as a result of increased market volatility, decreased market liquidity, or third-party financing being unavailable on terms acceptable to the Company or at all. The impact of these events on the world economy and the specific impact on the Company’s financial position, results of operations and/or ability to consummate an initial business combination are not yet determinable. The unaudited financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

9 

 

 

Note 2. Significant accounting policies

 

Basis of Presentation

 

The accompanying unaudited financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC. The interim financial information provided is unaudited but includes all adjustments, consisting only of normal recurring adjustments, which management considers necessary for the fair presentation of the results for the period. Operating results for the nine months ended September 30, 2026 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2026. The information included in this Form 10-Q should be read in conjunction with information included in the Company’s annual report on Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission on May 28, 2026.

 

Emerging Growth Company Status

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, as amended, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

 

The preparation of unaudited financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

 

Cash

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company has cash of $30,962 and $5,135 as of September 30, 2026 and December 31, 2025, respectively.

 

10 

 

 

Cash and Investments Held in Trust Account

 

As of September 30, 2026 and December 31, 2025, substantially all of the assets of $93,579,630 and $89,444,533 held in the trust account were invested primarily in money market funds. These investments are presented on the balance sheet at fair value at the end of each reporting period. Earnings on these investments are included in interest and dividends income in the accompanying statements of operations and are automatically reinvested. The fair value for these investments is determined using quoted market prices in active markets.

 

Offering Costs

 

The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A, Expenses of Offering. Deferred offering costs consist of underwriting, legal, and other expenses incurred through the balance sheet date that are directly related to the Initial Public Offering and were charged to shareholders’ equity upon the completion of the Initial Public Offering.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation (“FDIC”) of $250,000. As of September 30, 2026 and December 31, 2025, $0 was over the FDIC limit. The Company has not experienced losses on these accounts.

 

Net Income Per Share

 

The Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. Net income per ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding for the period. Remeasurement of carrying value to redemption value of redeemable ordinary shares is excluded from income per share as the redemption value approximates fair value. For the three and nine months ended September 30, 2026 and 2025, the Company has not considered the effect of the 8,755,000 Rights included in the Units, the Private Placement Units, the Option Units and the Additional Private Placement Units, in the calculation of diluted net income per share, since the conversion of the Rights is contingent upon the occurrence of future events and the inclusion of such Rights would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted income per share is the same as basic income per share for the periods presented.

 

    Three Months Ended
September 30, 2026
    Three Months Ended
September 30, 2025
 
    Redeemable
Class A
    Non-redeemable
Class A and
Class B
    Redeemable
Class A
    Non-redeemable
Class A and
Class B
 
Basic and diluted net income per ordinary share:                        
Numerator: allocation of net income   $ 107,073     $ 31,051     $ 625,573     $ 181,416  
Denominator: basic and diluted weighted average shares outstanding     8,500,000       2,465,000       8,500,000       2,465,000  
Basic and diluted net income per ordinary share   $ 0.01     $ 0.01     $ 0.07     $ 0.07  

 

    Nine Months Ended
September 30, 2026
    Nine Months Ended
September 30, 2025
 
    Redeemable
Class A
    Non-redeemable
Class A and
Class B
    Redeemable
Class A
    Non-redeemable
Class A and
Class B
 
Basic and diluted net income per ordinary share:                        
Numerator: allocation of net income   $ 1,089,738     $ 316,024     $ 1,795,558     $ 520,712  
Denominator: basic and diluted weighted average shares outstanding     8,500,000       2,465,000       8,500,000       2,465,000  
Basic and diluted net income per ordinary share   $ 0.13     $ 0.13     $ 0.21     $ 0.21  

 

11 

 

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

 

The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.

 

● Level 1: Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities.

 

● Level 2: Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.

 

● Level 3: Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.

 

The following table presents information about the Company’s assets that are measured at fair value on September 30, 2026 and December 31, 2025 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

 

    Carrying
Value
    Quoted
Prices in
Active
Markets
(Level 1)
    Significant
Other
Observable
Inputs
(Level 2)
    Significant
Other
Unobservable
Inputs
(Level 3)
 
September 30, 2026                        
Assets:                        
Cash and investments held in trust account   $ 93,579,630     $ 93,579,630     $       -     $        -  

 

    Carrying
Value
    Quoted
Prices in
Active
Markets
(Level 1)
    Significant
Other
Observable
Inputs
(Level 2)
    Significant
Other
Unobservable
Inputs
(Level 3)
 
December 31, 2025                        
Assets:                        
Cash and investments held in trust account   $ 89,444,533     $ 89,444,533     $         -     $       -  

 

12 

 

 

The fair value of the Rights included in the Units sold in the IPO was estimated as of the date of the IPO solely for purposes of allocating the proceeds of the IPO between the Class A ordinary shares and the Rights. The Rights were valued using a market approach, which applied the conversion ratio of one-eighth of one Class A ordinary share per Right to the quoted trading price of the Class A ordinary share of $9.96, adjusted for an implied probability of the completion of an initial business combination of 11.0%, derived from the market prices of rights of comparable special purpose acquisition companies, and a discount for lack of marketability of 1.0%. This resulted in a fair value of approximately $0.14 per Right. The Rights were classified as Level 3 at the measurement date due to the use of unobservable inputs, including the implied probability of the completion of an initial business combination and the discount for lack of marketability. The Rights are classified within shareholders’ equity and are not subsequently remeasured.

 

Class A ordinary shares subject to possible redemption

 

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480, “Distinguishing Liabilities from Equity” (ASC 480). Ordinary shares subject to mandatory redemption (if any) will be classified as a liability instrument and will be measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) will be classified as temporary equity. At all other times, ordinary shares will be classified as shareholders’ equity. In accordance with ASC 480-10-S99, the Company classifies the Class A ordinary shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. Given that the 8,500,000 Class A ordinary shares sold as part of the Units in the IPO were issued with other freestanding instruments (i.e., rights), the initial carrying value of Class A ordinary shares classified as temporary equity has been allocated to the proceeds determined in accordance with ASC 470-20. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period.

 

As of September 30, 2026 and December 31, 2025, the Class A ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:

 

Class A ordinary shares subject to possible redemption, December 31, 2024   $ 85,870,124  
Plus: remeasurement of carrying value to redemption value     3,574,409  
Class A ordinary shares subject to possible redemption, December 31, 2025     89,444,533  
Plus: remeasurement of carrying value to redemption value     2,435,097  
Plus: extension deposits into trust account     1,700,000  
Class A ordinary shares subject to possible redemption, September 30, 2026   $ 93,579,630  

 

Income Taxes

 

The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

 

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s unaudited financial statements.

 

13 

 

 

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2026 and December 31, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited financial statements.

 

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

Recent Accounting Pronouncements

 

In November 2024, the FASB issued Accounting Standards Update (“ASU”) 2024-03, “Income Statement, Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses”, requiring public entities to disclose additional information about specific expense categories in the notes to the unaudited financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.

 

Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited financial statements.

 

Note 3. Initial Public Offering

 

On October 25, 2024, the Company sold 7,500,000 Units in its IPO. On November 19, 2024, the Representative exercised the over-allotment option in part, and purchased 1,000,000 Units. Each Unit has an offering price of $10.00 and consists of one share of the Company’s Class A ordinary share and one right. Each right entitles the holder thereof to receive one-eighth of one Class A ordinary share upon completion of the Company’s initial business combination. The Company will not issue fractional shares. As a result, the holder must hold rights in multiples of 8 in order to receive shares for all of their rights upon closing of an initial business combination.

 

Note 4. Private Placement

 

Simultaneously with the closing of the IPO and the Option Units in part, the sponsor purchased an aggregate of 255,000 Units at a price of $10.00 per Unit for an aggregate purchase price of $2,550,000 in the Private Placement. Each Private Placement Unit is identical to the Units sold in the IPO, except that it will not be redeemable, transferable, assignable or salable by the sponsor until the completion of its initial business combination (except to certain permitted transferees).

 

14 

 

 

Note 5. Related Party Transactions

 

Founder Shares

 

On April 23, 2024, the Company issued 2,156,250 Class B ordinary shares, or founder shares, par value $0.0001 per share, to its Sponsor for a purchase price of $25,000, or approximately $0.0116 per share. On November 19, 2024, the underwriters partially exercised the over-allotment option for an additional 1,000,000 Units, reducing the Class B ordinary shares subject to forfeiture to 31,250 shares. On December 9, 2024, the remainder of the over-allotment option to purchase 125,000 Units expired and the 31,250 founder shares were forfeited, resulting in the insiders collectively owning 20.0% of its issued and outstanding shares after the IPO (without giving effect to the sale of the Private Placement Units, the Representative Shares, and assuming the Company’s insiders do not purchase Units in the IPO).

 

On September 11, 2024, the sponsor entered into a securities transfer agreement, pursuant to which the sponsor transferred 100,000 founder shares and 60,000 founder shares to Mr. Will Garner, the Company’s former Chairman and CEO, and Ms. Yuanmei Ma, the Company’s former CFO, respectively, for a total consideration of $1,855, or approximately $0.0116 per share. The transfer of the 160,000 founder shares is accounted for as compensation under Accounting Standards Codification (“ASC”) 718, “Compensation: Stock Compensation” (“ASC 718”). The estimated fair value of the 160,000 founder shares totaled $187,200. On September 11, 2024, the Company recognized a share-based compensation expense of $185,345, net of the nominal cash consideration of $1,855 paid by the officers.

 

On October 24, 2024, the effective date of the registration statement of the IPO, the sponsor transferred an aggregate of 60,000 of its founder shares, or 20,000 each to its three independent directors for their board service, for nominal cash consideration, of $696. The transfer of the 60,000 founder shares is accounted for as compensation under Accounting Standards Codification (“ASC”) 718, “Compensation: Stock Compensation” (“ASC 718”). The estimated fair value of the 60,000 founder shares totaled $65,046. On October 24, 2024, the Company recognized a share-based compensation expense of $64,350, net of the nominal cash consideration of $696 paid by the directors.

 

The Private Placement shares are identical to the Class A ordinary shares included in the Units sold in the IPO. However, the Company’s insiders have agreed, pursuant to written letter agreements with the Company, (A) to vote their founder shares and Private Placement shares (as well as any public shares acquired in or after the IPO) in favor of any initial business combination, (B) not to propose, or vote in favor of, an amendment to the Company’s memorandum and articles of association effective at the time that would stop the Company’s public shareholders from redeeming their shares for cash or selling their founder shares and Private Placement shares to the Company in connection with an initial business combination or affect the substance or timing of the Company’s obligation to redeem 100% of the Company’s public shares if the Company does not complete an initial business combination by the Combination Deadline, (C) not to redeem any founder shares and Private Placement shares (as well as any other shares acquired in or after the IPO) for cash from the trust account in connection with a shareholder vote to approve the Company’s proposed an initial business combination (or sell any shares they hold to the Company in a tender offer in connection with a proposed initial business combination) or a vote to amend the provisions of the Company’s memorandum and articles of association effective at the time relating to shareholders’ rights or pre-initial business combination activity and (D) that the founder shares and Private Placement shares shall not participate in any liquidating distribution upon winding up if an initial business combination is not consummated.

 

15 

 

 

The insiders have agreed not to transfer, assign or sell any of the founder shares (except to certain permitted transferees) until (1) with respect to 50% of the founder shares, the earlier of six months after the date of the consummation of the Company’s initial business combination and the date on which the closing price of the Company’s ordinary shares equals or exceeds $12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the Company’s initial business combination and (2) with respect to the remaining 50% of the founder shares, six months after the date of the consummation of the Company’s initial business combination, or earlier, in either case, if, subsequent to the Company’s initial business combination, the Company consummate a liquidation, merger, share exchange or other similar transaction which results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property.

 

The Private Placement Units (including the underlying securities) will not be transferable, assignable or saleable until the completion of the Company’s initial business combination (except to certain permitted transferees).

 

Due to related parties

 

On June 14, 2024, the Company appointed Mr. Will Garner as Chairman, Chief Executive Officer (“former CEO”) and a member of board of directors of the Company. During his term as Chairman and CEO, he received monthly cash compensation of $7,500, payable each month. On February 2, 2026, Mr. Will Garner resigned all the positions he held at the Company.

 

As of September 30, 2026 and December 31, 2025, the Company had compensation expenses payable to Mr. Will Garner of $46,250 and $38,750, respectively. Following his resignation, the balance of $46,250 as of September 30, 2026 was reclassified from amounts due to a related party to accrued expenses, as Mr. Garner is no longer considered a related party.

 

On May 25, 2024, the Company appointed Ms. Yuanmei Ma as Chief Financial Officer (“former CFO”), in addition to her current position as a member of the board of the directors. During her term as CFO and a member of board of directors of the Company, she received monthly cash compensation of $5,000, payable each month. On March 24, 2026, Ms. Yuanmei Ma resigned all the positions she held at the Company.

 

As of September 30, 2026 and December 31, 2025, the Company had compensation expenses payable to Ms. Yuanmei Ma of $40,000 and $25,000, respectively. Following her resignation, the balance of $40,000 as of September 30, 2026 was reclassified from amounts due to a related party to accrued expenses, as Ms. Ma is no longer considered a related party.

 

On March 26, 2026, the Company appointed Mr. Jung Min Lee as the new Chief Executive Officer (“CEO”) and a director of the Company. The Company also appointed Mr. Jung Min Lee as the acting Chief Financial Officer of the Company until a new full time Chief Financial Officer is appointed. During his term as CEO and a member of board of directors of the Company, he will receive monthly cash compensation of $7,500, payable each month.

 

As of September 30, 2026, the Company had compensation expenses payable to Mr. Jung Min Lee of $46,210.

 

On July 22, 2026, the Company appointed Mr. Paul Strickland as the new Chief Financial Officer (“CFO”) and a director of the Company. Accordingly, Mr. Jung Min Lee ceased to serve as the acting Chief Financial Officer of the Company, effective July 22, 2026. During Mr. Paul Strickland’s term as CFO and a member of board of directors of the Company, he will receive monthly cash compensation of $5,000, accruing on a monthly basis. Payment of such accrued amounts shall be deferred, except a one-time $5,000 payment, and made in a single lump sum upon consummation of the Company’s Business Combination, without interest.

 

As of September 30, 2026, the Company had compensation expenses payable to Mr. Paul Strickland of $6,613, after a payment to him of $5,000 of his August 2026 salary on August 27, 2026.   

 

16 

 

 

Leading Edge Advisory

 

On May 30, 2026, the Company engaged Leading Edge Advisory Inc. (“LEA”) under a General Accounting Consulting Agreement. Amendment No. 1 to that agreement, dated July 8, 2026, extended LEA’s services to Korea Quantum Computing Co., Ltd. (“KQC Korea”) and provides that KQC Korea bears LEA’s fees, paid through the Company. Mr. Kyoung Tak Kim, who became a director of the Company on July 22, 2026, is a partner of LEA. Mr. Kim also served as a member of the Company’s audit committee from July 22, 2026 until October 22, 2026. Because Mr. Kim is a director of the Company, the Company considers LEA to be a related party under ASC 850 from July 22, 2026. The agreement and the invoice described below predated Mr. Kim’s appointment to the board of directors.

 

On August 25, 2026, the Company paid LEA $30,000 under an invoice dated July 6, 2026 issued to the Company. The payment was funded with Working Capital Loans from the sponsor, evidenced by a promissory note issued by the Company to the sponsor (see “Working Capital Loans” below). No other amount had been invoiced by or paid to LEA as of September 30, 2026, and no amount was due to LEA as of September 30, 2026.

 

Promissory Note, Related Party

 

On April 18, 2024, the sponsor has agreed to loan the Company up to $500,000 (the “Promissory Note”) to be used for a portion of the expenses of the IPO. The Promissory Note of $273,969 is non-interest bearing, unsecured and is due at the earlier of (1) December 31, 2024 or (2) the date on which the Company consummates an initial public offering. The Promissory Note was repaid upon the closing of the IPO out of the offering proceeds not held in the trust account. As of September 30, 2026 and December 31, 2025, the Company had no amounts outstanding under the Promissory Note. Following the completion of the IPO, the Promissory Note was no longer available and replaced with the Working Capital Loans (as defined below).

 

Working Capital Loans

 

In addition, in order to meet the Company’s working capital needs following the consummation of the initial public offering if the funds not held in the trust account are insufficient, or to extend its life, its insiders, officers and directors or their affiliates/designees may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. Each loan to meet the Company’s working capital needs would be deposited into the operating account and evidenced by a promissory note. Each loan to extend the Company’s business combination date would be deposited into the trust account and evidenced by a promissory note. The notes would either be paid upon consummation of the Company’s initial business combination, without interest, or, at the lender’s discretion, up to $3,000,000 of the notes (“Working Capital Loans”) may be converted upon consummation of the Company’s initial business combination into Private Placement Units at a price of $10.00 per Unit. If the Company does not complete an initial business combination, the loans would be repaid out of funds not held in the trust account, and only to the extent available.

 

On April 17, 2026 and August 25, 2026, the sponsor agreed to loan the Company up to an aggregated $1,000,000 to meet the Company’s working capital needs. This amount relates solely to loans to fund the Company’s working capital needs and does not include the loans made by the sponsor to fund the extension deposits described below. The loan was evidenced by a promissory note that was non-interest bearing and unsecured, and it was to be paid upon the earlier of (1) the date on which the Company consummates a business combination or merger with a qualified target company, and (2) the date of the liquidation of the Company. The sponsor has the right, but not the obligation, to convert this loan, in whole or in part, into Private Placement Units of the Company, each consisting of one Class A ordinary share, one right to receive one-eighth of one Class A ordinary share. The number of Private Placement Units to be received by the Sponsor in connection with such conversion shall be an amount determined by dividing (x) the sum of the outstanding principal amount payable to the sponsor by (y) $10.00. As of September 30, 2026, $681,879 had been drawn for working capital needs under these notes, leaving $318,121 available.

 

17 

 

 

On April 24, 2026 and August 3, 2026, the sponsor deposited an aggregated $1,700,000 into the trust account, as a result of which, the Company had until October 25, 2026 to complete its initial business combination. The $1,700,000 loan from sponsor to extend the Company’s business combination date was evidenced by promissory notes with terms consistent with those of Working Capital Loans for working capital needs.

 

As of September 30, 2026 and December 31, 2025, the Company had borrowings under the Working Capital Loans from the sponsor of $2,381,879, which included $1,700,000 for extensions and $681,879 for working capital needs, and $100,881, which was for working capital needs, respectively.  

 

The Company evaluated the conversion feature of the Working Capital Loans under ASC 815-15, “Derivatives and Hedging – Embedded Derivatives,” and concluded that the conversion feature is not an embedded derivative requiring bifurcation and separate accounting. The Company also evaluated the Working Capital Loans under ASC 470-20, “Debt with Conversion and Other Options,” and concluded that no portion of the proceeds is required to be allocated to the conversion feature. Accordingly, the Working Capital Loans are recorded at their outstanding principal amount.

 

Note 6. Commitments and Contingencies

 

Registration Rights

 

The holders of the founder shares and Private Placement Units, including any Working Capital Units issued upon conversion of Working Capital Loans will be entitled to registration rights pursuant to a registration rights agreement signed on October 24, 2024 by and among the Company and the insiders. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of the Company’s initial business combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

The Company had granted the underwriter a 45-day option to purchase up to an additional 1,125,000 Units solely to cover over-allotments, if any. The underwriters exercised the over-allotment option in part and purchased 1,000,000 Option Units on November 19, 2024.

 

The underwriter was entitled to cash underwriting discounts and commissions of $0.15 per Unit, or $1,275,000, and paid at the closing of the IPO and the Option Units in part. In connection with the IPO, the underwriter was issued an aggregate of 85,000 Class A ordinary shares, or Representative Shares, with a fair value of $92,195. The Representative Shares were valued using a market approach based on the quoted trading price of Class A ordinary shares of $9.96 per share, adjusted for the probability of a business combination between a Special Purpose Acquisition Company and a private operating company of 11.0% and a discount for lack of marketability of 1.0%.

 

Additionally, the underwriter will be entitled to cash underwriting discounts and commissions of $0.20 per Unit, or $1,700,000, at the closing of the initial business combination as deferred underwriting fee. If the Company does not complete its initial business combination within the time period required by its second amended and restated memorandum and articles of association, the underwriters have agreed that (i) they will forfeit any rights or claims to their deferred underwriting discounts and commissions, including any accrued interest thereon, then in the trust account, and (ii) that the deferred underwriters’ discounts and commissions will be included with the funds held in the trust account that will be available to fund the redemption of our public shares.

 

As of September 30, 2026 and December 31, 2025, deferred underwriting discounts and commissions amounted to $1,700,000 payable upon consummation of the Company’s initial business combination.

 

18 

 

 

De-SPAC Cost Funding Agreement

 

On July 8, 2026, the Company and KQC Korea entered into a side letter agreement under which KQC Korea agreed to fund the costs of the proposed business combination, up to $2,500,000 unless the parties agree otherwise, either by paying service providers directly or by advancing funds to the Company. Each advance was to be evidenced by a non-interest bearing, unsecured promissory note issued by the Company to KQC Korea. After the closing of the business combination, KQC Korea could elect to have the notes repaid in cash or converted at $10.00 per share or unit. As of September 30, 2026, KQC Korea had made no advance to the Company and the Company had issued no note to KQC Korea. On October 6, 2026, the Business Combination Agreement replaced this arrangement. Under Section 5.12 of the Business Combination Agreement, KQC Quantum, Inc. (“Parent”) is responsible for all De-SPAC Costs, as defined therein, up to $2,500,000, either by paying service providers directly or by advancing funds to the Company for payment to service providers, and Parent is not entitled to reimbursement of any amount so paid or advanced. The $2,500,000 cap does not apply to the costs of the D&O tail policy and the SPAC fairness opinion, costs required by applicable law or in connection with SEC or Nasdaq filings, or extension costs. Advances under Section 5.12 are not loans of the Company and are not convertible into securities of the Company. See Note 9. As of September 30, 2026, Parent had made no advance to the Company.

 

Note 7. Shareholders’ Deficit

 

Preference Share. The Company is authorized to issue 5,000,000 shares of preference share, $0.0001 par value, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2026 and December 31, 2025, there were no preference shares issued and outstanding.

 

Class A Ordinary Share. The Company is authorized to issue 445,000,000 Class A ordinary share with $0.0001 par value. As of September 30, 2026 and December 31, 2025, there were 340,000 Class A ordinary shares issued and outstanding, excluding 8,500,000 Class A ordinary shares subject to possible redemption.

 

Class B Ordinary Share. The Company is authorized to issue 50,000,000 Class B ordinary share with $0.0001 par value. In April 2024, the Company issued an aggregate of 2,156,250 founder shares to the sponsor for an aggregate purchase price of $25,000, or approximately $0.0116 per share. Of the aggregate 2,156,250 Class B ordinary shares outstanding, an aggregate of 31,250 shares were forfeited to the Company by the sponsor for no consideration to the extent that the underwriter’s over-allotment option was exercised in part, so that the initial shareholders would collectively own 20.0% of the Company’s issued and outstanding shares of ordinary share after the IPO (without giving effect to the sale of the Private Placement Units, the Representative Shares, and assuming the Company’s insiders do not purchase Units in the IPO). As of September 30, 2026 and December 31, 2025, there were 2,125,000 Class B ordinary shares issued and outstanding.

 

On September 11, 2024, the sponsor transferred an aggregate of 160,000 of its founder shares, or 100,000 of its founder shares and 60,000 of its founder shares to Mr. Garner, the Company’s former Chairman and former CEO, and Ms. Ma, the Company’s former CFO, respectively, for their officer services (See Note 5).

 

On October 24, 2024, the effective date of the registration statement of the IPO, the sponsor transferred an aggregate of 60,000 of its founder shares, or 20,000 each to the Company’s three independent directors for their board service (See Note 5).

 

Prior to the Company’s initial business combination, pursuant to its second amended and restated memorandum and articles of association, only holders of Class B ordinary shares, or founder shares will have the right to vote on the appointment of directors. Holders of the Company’s Class A ordinary shares will not be entitled to vote on the appointment of directors as long as the Company has Class B ordinary shares issued and outstanding. In addition, prior to its initial business combination, only holders of a majority of the Company’s Class B ordinary shares may remove a member of the board of directors for any reason. Accordingly, holders of Class A ordinary shares may not have any say in selecting management of the Company prior to the consummation of an initial business combination as long as the Company has Class B ordinary shares issued and outstanding.

 

The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial business combination, or earlier at the option of the holder, at a one-to-one ratio.

 

19 

 

 

Rights

 

As of September 30, 2026 and December 31, 2025, there were 8,500,000 Public Rights and 255,000 private rights included in the Private Placement Units (“Private Rights”) outstanding. Except in cases where the Company is not the surviving company in an initial business combination, each holder of a right will automatically receive one-eighth of one Class A ordinary share upon consummation of the Company’s initial business combination. In the event the Company will not be the surviving company upon completion of the Company’s initial business combination, each right will automatically be converted to receive the kind and amount of securities or properties of the surviving entity that each one-eighth of one Class A ordinary share underlying each right is entitled to upon consummation of the initial business combination subject to any dissenter rights under the applicable law. The Company will not issue fractional shares in connection with a conversion of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of the Companies Act and any other applicable Cayman Islands law. As a result, holders must hold rights in multiples of eight in order to receive shares for all of their rights upon closing of an initial business combination. If the Company is unable to complete an initial business combination within the required time period and the Company redeems the public shares for the funds held in the trust account, holders of rights will not receive any of such funds for their rights and the rights will expire worthless. The Company shall reserve such amount of its profits or share premium in order to pay up the par value of each share issuable in respect of the rights.

 

Note 8. Segment Information

 

ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statements information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker, or group, in deciding how to allocate resources and assess performance.

 

The Company’s chief operating decision maker has been identified as the Chief Executive Officer (“CODM”), who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating segment.

 

When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews the key metric, which include the following:

 

    Three Months
Ended
September 30,
2026
    Three Months
Ended
September 30,
2025
    Nine Months
Ended
September 30,
2026
    Nine Months
Ended
September 30,
2025
 
Professional fees incurred in connection with potential business combination   $ (564,145 )   $ -     $ (614,145 )   $ -  
Other formation and operating costs     (142,319 )     (109,077 )     (415,191 )     (406,709 )
Interest and dividend income on cash and investments held in trust account and interest income     844,588       916,066       2,435,098       2,722,979  
Net income   $ 138,124     $ 806,989     $ 1,405,762     $ 2,316,270  

 

The key measures of segment profit or loss reviewed by the Company’s CODM are interest and dividends earned on cash and investment held in Trust Account and formation and operating costs. The CODM reviews interest and dividends earned on cash and investment held in Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the trust agreement. Formation and operating costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination within the business combination period. The CODM also reviews formation and operating costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget.

 

20 

 

 

Note 9. Subsequent Events

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date when these unaudited financial statements were issued. Based on this review, other than the events described below, the Company did not identify any subsequent events that would require adjustment or disclosure in the unaudited financial statements.

 

On October 6, 2026, the Company entered into a Business Combination Agreement (the “Business Combination Agreement”) with KQC Quantum, Inc., a Delaware corporation (“Parent”), KQC MS Limited, a Cayman Islands exempted company and a wholly owned subsidiary of Parent (“Merger Sub”), and, for the limited purposes specified therein, Korea Quantum Computing Co., Ltd., a corporation organized under the laws of the Republic of Korea, and the sponsor. Pursuant to the Business Combination Agreement, and subject to the satisfaction or waiver of the conditions set forth therein, Merger Sub will merge with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent. The Business Combination Agreement provides for an equity value of Parent of $80,000,000 and for up to 1,500,000 earnout shares. Closing is subject to customary conditions, including approval by the Company’s shareholders, the effectiveness of a registration statement on Form S-4, approval for listing on The Nasdaq Stock Market LLC, approval of an extension of the Company’s deadline to complete a business combination, and aggregate cash available at closing, including funds remaining in the trust account after redemptions and the net proceeds of any private placement financing, of not less than $30,000,000. There can be no assurance that the transactions contemplated by the Business Combination Agreement will be completed.

 

Concurrently with the execution of the Business Combination Agreement, the Company, Parent and the sponsor entered into a Sponsor Support Agreement, pursuant to which the sponsor agreed, among other things, to vote all of its Class A ordinary shares underlying the Private Placement Units and its founder shares in favor of the proposals to be submitted to the Company’s shareholders in connection with the transactions contemplated by the Business Combination Agreement, and not to redeem any such shares, including in connection with any meeting convened to approve an extension of the Combination Deadline. In addition, on October 6, 2026, the Company, Parent and certain stockholders of Parent entered into a Parent Support Agreement, pursuant to which such stockholders agreed, among other things, to vote their shares of Parent common stock in favor of the transactions contemplated by the Business Combination Agreement.

 

On October 8, 2026, the Company engaged Clear Street LLC, the representative of the underwriters in the IPO, as its financial and capital markets advisor for the business combination. The Company will pay Clear Street LLC a fee of $200,000 only if the business combination is completed, from funds available to the combined company at the closing.   This advisory fee is separate from, and in addition to, the $1,700,000 deferred underwriting fee payable to Clear Street LLC upon consummation of the initial business combination. The engagement did not change the amount or terms of the deferred underwriting fee.

 

On October 19, 2026, the Company held an extraordinary general meeting of its shareholders (the “Extension Meeting”). The shareholders approved, by special resolution, (i) an amendment to the Company’s second amended and restated memorandum and articles of association to extend the date by which the Company must complete an initial business combination from October 25, 2026 up to twelve times, by one month each time, to as late as October 25, 2027, and (ii) Amendment No. 1 to the Investment Management Trust Agreement to permit those extensions. For each one-month extension, the sponsor, or one or more of its affiliates or designees, must deposit into the trust account $0.03 for each public share that remains outstanding, up to $60,000 per extension. Each deposit will be treated as a loan to the Company.

 

In connection with the Extension Meeting, holders of 5,725,962 public shares exercised their right to redeem their shares for approximately $11.03 per share, or $63,157,704 in aggregate, paid from the trust account. Following the redemptions, 2,774,038 public shares remain outstanding, and $30,597,806 remained in the trust account. Each one-month extension therefore requires a deposit of $60,000.

 

On October 19, 2026, the sponsor converted 1,464,999 Class B ordinary shares into the same number of Class A ordinary shares, on a one-for-one basis, in accordance with the Company’s memorandum and articles of association. The sponsor has acknowledged that the Class A ordinary shares it received on the conversion are not entitled to any distribution from the trust account. Following the conversion and the redemptions, 4,579,037 Class A ordinary shares and 660,001 Class B ordinary shares are issued and outstanding.

 

On October 27, 2026, the Company deposited $60,000 into the trust account to extend the Combination Deadline from October 25, 2026 to November 25, 2026. The Company funded the deposit from its operating account. On October 26, 2026, the Company received an advance of $250,000 of De-SPAC Costs from Parent under Section 5.12 of the Business Combination Agreement, including the amount of the deposit. The advance is not repayable by the Company.

 

21 

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

References in this report (the “Quarterly Report”) to “we,” “us”, or the “Company” refer to Charlton Aria Acquisition Corporation. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to ST Sponsor II Limited. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

 

Special Note Regarding Forward-Looking Statements

 

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and variations thereof and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s final prospectus for its initial public offering (the “IPO” described below) filed with the Securities and Exchange Commission (the “SEC”) on October 24, 2024 (File No. 333-282313) (the “Prospectus”) the risk factors in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, and the risk factors in the Company’s definitive proxy statement filed with the SEC on October 7, 2026. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

 

Overview

 

Charlton Aria Acquisition Corporation (the “Company”) is a blank check company incorporated in the Cayman Islands on March 22, 2024 as an exempted company with limited liability. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). We intend to effectuate our Business Combination using cash from the proceeds of our IPO and the sale of our shares, debt or a combination of cash, equity and debt. We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

 

22 

 

 

Our Initial Public Offering

 

On October 25, 2024, we consummated our IPO of 7,500,000 units (the “Public Units”), each Public Unit consisting of one Class A ordinary share (the “Class A Ordinary Shares”) of the Company, par value $0.0001 per share (the “Public Shares”), and one right (the “Rights”) of the Company, each right entitling the holder to receive one-eighth of one Class A Ordinary Share (the “Public Rights”). The Public Units were sold at a price of $10.00 per Unit, and the IPO generated gross proceeds of $75,000,000. Simultaneously with the closing of the IPO, we consummated a private placement (the “Private Placement”) with ST Sponsor II Limited, our sponsor (the “sponsor”), of an aggregate of 240,000 units (the “Private Placement Units”) at a price of $10.00 per Private Placement Unit, generating gross proceeds to the Company of $2,400,000. Each Private Placement Unit consists of one Class A ordinary share (the “Private Placement Shares”), and one Right (the “Private Placement Rights”). The terms and provisions of the Private Placement Shares and Private Placement Rights in the Private Placement Units are identical to the Public Shares and Public Rights, respectively, except that, subject to certain limited exceptions, the Private Placement Shares are subject to transfer restrictions until the consummation of the Company’s initial business combination. On October 25, 2024, a total of $75,187,500 of the net proceeds from the IPO and the Private Placement was deposited in a trust account (the “trust account”) established for the benefit of the Company’s Public Shareholders at a U.S. based trust account, with Continental Stock Transfer & Trust Company, acting as trustee.

 

We also issued to Clear Street LLC, the representative of the underwriters of the IPO (the “Representative”), 75,000 Class A Ordinary Shares as part of the underwriting compensation (the “Representative Shares”) on the closing of the IPO. The Representative Shares are identical to the Class A Ordinary Shares included in the Units, with certain exceptions.

 

The underwriters were granted a 45-day option to purchase up to an additional 1,125,000 units offered by the Company to cover over-allotments, if any. On November 19, 2024, the Representative exercised the Over-allotment Option in part, and purchased 1,000,000 Units (the “Option Units”), generating gross proceeds of $10,000,000. Simultaneously with the issuance and sale of the Option Units, the Company completed a private placement sale of 15,000 Private Placement Units (the “Additional Private Placement Units”) to the sponsor at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds of $150,000. The Company also issued an additional 10,000 Representative Shares to the Representative.

 

Since our IPO, our sole business activity has been identifying, evaluating suitable acquisition transaction candidates and preparing for consummation of an initial business combination. We presently have no revenue and have incurred formation and operating costs since inception. Our net income for the three and nine months ended September 30, 2026 and 2025 was attributable to interest and dividends earned on investments held in trust account, which exceeded our formation and operating costs. We have relied upon the sale of our securities and loans from the sponsor and other parties to fund our operations.

 

In connection with the offering of the Option Units and the sale of Additional Private Placement Units, the proceeds of $10,025,000 from the proceeds of the offering of the Option Units and the sale of Additional Private Placement Units were placed in the trust account established for the benefit of the Company’s public shareholders and the underwriters of the IPO, with Continental Stock Transfer & Trust Company acting as trustee.

 

The Private Placement Units were issued pursuant to the exemption from registration contained in Section 4(a) (2) of the Securities Act. No commissions were paid in connection with such sales.

 

Separation of Units

 

On November 25, 2024, the Company announced that holders of the Company’s Public Units may elect to separately trade the Public Shares and Public Rights from the Public Units, commencing on or about November 26, 2024.

 

The Class A ordinary shares and rights trade on the Nasdaq Global Market (“Nasdaq”) under the symbols “CHAR” and “CHARR”, respectively. Units not separated continue to trade on Nasdaq under the symbol “CHARU.”

 

23 

 

 

Cancellation of Founder Shares

 

On December 9, 2024, after the expiration of the Over-Allotment Option, pursuant to the IPO Prospectus and the founder share purchase agreement between the Company and the sponsor, the Company and the sponsor agreed to cancel 31,250 Class B ordinary shares of the Company so that our insiders would collectively own 20.0% of our issued and outstanding shares after the IPO. As a result, 2,125,000 founder shares remained issued and outstanding.

 

Change in Control of Sponsor

 

On May 13, 2025, Sunny Tan Kah Wei, the sole shareholder of our sponsor, closed upon the transaction provided for by a Share Purchase Agreement (the “Sponsor Sale SPA”), dated as of May 12, 2025, with Sovereign Global Trust LLC, a Delaware limited liability company (“Buyer”).

 

Pursuant to the Sponsor Sale SPA, Mr. Wei sold all of his shares in the sponsor, representing a 100% interest therein, to Buyer, and Buyer became the sole shareholder of our sponsor. The purchase price was $4,000,000 consisting of funds held by Buyer for investment purposes, paid in cash at closing, plus customary transaction costs. This transaction is referred to below as the “Sponsor Transaction.”

 

Buyer’s sole member and sole manager is Valley Point Limited, a British Virgin Islands corporation (“Valley Point”). Accordingly, Valley Point is now the sole shareholder of the sponsor and as such is deemed to have sole voting and investment discretion with respect to our shares and other securities held by the sponsor. Valley Point’s sole member and sole manager is Chen Siak Chan, a resident and citizen of Singapore. Accordingly, Chen Siak Chan, in his capacity as sole member and sole manager of Valley Point, the sole shareholder of the sponsor, is also deemed to have sole voting and investment discretion with respect to our shares and other securities held by the sponsor.

 

Extensions

 

Pursuant to the Second Amended and Restated Memorandum and Articles of Association of the Company, the Company had until April 25, 2026, or 18 months from the consummation of its initial public offering to consummate its initial business combination, provided that the Company may, but is not obligated to, extend the period of time to consummate an initial business combination two times by an additional three months each time (until July 25, 2026 or October 25, 2026, or up to 21 months or 24 months from the consummation of the IPO to complete an initial business combination) if the Sponsor and/or its designees deposit into the trust account $850,000 for each three months extension, for an aggregate of up to $1,700,000.

 

On April 24, 2026, the Sponsor deposited $850,000 into the trust account, as a result of which, the Company had until July 25, 2026 to complete its initial business combination (the “First Extension”). In connection with the First Extension, the Company issued an unsecured promissory note dated April 23, 2026, in the principal amount of $850,000 to the Sponsor. The promissory note does not bear interest, except that overdue amounts accrue default interest at the prevailing short-term U.S. Treasury Bill rate, and the outstanding principal is payable on the earlier of the consummation of the Company’s initial business combination and the Company’s liquidation.

 

On August 3, 2026, the Sponsor deposited $850,000 into the trust account, as a result of which, the Company had until October 25, 2026 to complete its initial business combination (the “Second Extension”). In connection with the Second Extension, the Company issued an unsecured promissory note dated July 31, 2026, in the principal amount of $850,000 to the Sponsor. The promissory note does not bear interest, except that overdue amounts accrue default interest at the prevailing short-term U.S. Treasury Bill rate, and the outstanding principal is payable on the earlier of the consummation of the Company’s initial business combination and the Company’s liquidation.

 

24 

 

 

On October 19, 2026, the Company held an extraordinary general meeting of its shareholders (the “Extension Meeting”). The shareholders approved, by special resolution, (i) an amendment to our second amended and restated memorandum and articles of association to extend the date by which the Company must complete an initial business combination from October 25, 2026 up to twelve times, by one month each time, to as late as October 25, 2027, and (ii) Amendment No. 1 to the Investment Management Trust Agreement to permit those extensions. For each one-month extension, the sponsor, or one or more of its affiliates or designees, must deposit into the trust account $0.03 for each public share that remains outstanding, up to $60,000 per extension. Each deposit will be treated as a loan to the Company.

 

In connection with the Extension Meeting, holders of 5,725,962 public shares exercised their right to redeem their shares for approximately $11.03 per share, or $63,157,704 in aggregate, paid from the trust account. Following the redemptions, 2,774,038 public shares remain outstanding, and $30,597,806 remained in the trust account. Each one-month extension therefore requires a deposit of $60,000.

 

On October 19, 2026, the sponsor converted 1,464,999 Class B ordinary shares into the same number of Class A ordinary shares, on a one-for-one basis, in accordance with the Company’s memorandum and articles of association. The sponsor has acknowledged that the Class A ordinary shares it received on the conversion are not entitled to any distribution from the trust account. Following the conversion and the redemptions, 4,579,037 Class A ordinary shares and 660,001 Class B ordinary shares are issued and outstanding.

 

On October 27, 2026, the Company deposited $60,000 into the trust account to extend the Combination Deadline from October 25, 2026 to November 25, 2026. The Company funded the deposit from its operating account. On October 26, 2026, the Company requested, and Parent approved, an advance of $500,000 of De-SPAC Costs to the Company under Section 5.12 of the Business Combination Agreement, including the amount of the deposit. The advance is not repayable by the Company.

 

Proposed Business Combination

 

On October 6, 2026, the Company entered into a Business Combination Agreement (the “Business Combination Agreement”) with KQC Quantum, Inc., a Delaware corporation (“Parent”), KQC MS Limited, a Cayman Islands exempted company and a wholly owned subsidiary of Parent (“Merger Sub”), and, for the limited purposes specified therein, Korea Quantum Computing Co., Ltd., a corporation organized under the laws of the Republic of Korea, and the Sponsor. Pursuant to the Business Combination Agreement, and subject to the satisfaction or waiver of the conditions set forth therein, Merger Sub will merge with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent. The Business Combination Agreement provides for an equity value of Parent of $80,000,000 and for up to 1,500,000 earnout shares. Closing is subject to customary conditions, including approval by the Company’s shareholders, the effectiveness of a registration statement on Form S-4, approval for listing on Nasdaq, approval of an extension of the Company’s deadline to complete a business combination, and aggregate cash available at closing, including funds remaining in the trust account after redemptions and the net proceeds of any private placement financing, of not less than $30,000,000. There can be no assurance that the transactions contemplated by the Business Combination Agreement will be completed.

 

Concurrently with the execution of the Business Combination Agreement, the Company, Parent and the Sponsor entered into a Sponsor Support Agreement, pursuant to which the Sponsor agreed, among other things, to vote all of its Class A ordinary shares underlying the Private Placement Units and its founder shares in favor of the proposals to be submitted to the Company’s shareholders in connection with the transactions contemplated by the Business Combination Agreement, and not to redeem any such shares, including in connection with any meeting convened to approve an extension of the Combination Deadline. In addition, on October 6, 2026, the Company, Parent and certain stockholders of Parent entered into a Parent Support Agreement, pursuant to which such stockholders agreed, among other things, to vote their shares of Parent common stock in favor of the transactions contemplated by the Business Combination Agreement.

 

25 

 

 

Results of Operations

 

We have neither engaged in any operations nor generated any revenues to date. Our only activities from March 22, 2024 (inception) to September 30, 2026 were organizational activities, those necessary to prepare for the IPO, described below, and, after the IPO, identifying a target company for an initial business combination. We do not expect to generate any operating revenues until after the completion of our initial business combination. We may generate non-operating income in the form of interest and dividends earned on investments held in the trust account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with completing an initial business combination.

 

For the three months ended September 30, 2026, we had a net income of $138,124, which consisted of interest and dividends earned on investments held in trust account of $844,588, which was partially offset by formation and operating costs of $706,464.

 

For the three months ended September 30, 2025, we had a net income of $806,989, which consisted of interest and dividends earned on investments held in trust account of $915,972 and interest income of $94, which was partially offset by formation and operating costs of $109,077.

 

For the nine months ended September 30, 2026, we had a net income of $1,405,762, which consisted of interest and dividends earned on investments held in trust account of $2,435,097 and interest income of $1, which was partially offset by formation and operating costs of $1,029,336.

 

For the nine months ended September 30, 2025, we had a net income of $2,316,270, which consisted of interest and dividends earned on investments held in trust account of $2,719,802 and interest income of $3,177, which was partially offset by formation and operating costs of $406,709.

 

Formation and operating costs increased by $597,387 for the three months, and by $622,627 for the nine months, ended September 30, 2026 compared with the same periods in 2025, mainly because of professional fees of $564,145 and $614,145, respectively, incurred in connection with the proposed business combination with KQC Quantum, Inc. Interest and dividends earned on investments held in the trust account decreased by $71,384 for the three months, and by $284,705 for the nine months, ended September 30, 2026, because of lower yields on the money market funds held in the trust account, partly offset by a higher trust balance following the extension deposits.

 

Liquidity and Capital Resources

 

The Company’s liquidity needs through September 30, 2026 were satisfied through the payment of $25,000 by the sponsor for the founder shares, the proceeds of the IPO and the private placements held outside the trust account, and loans from the sponsor under the Working Capital Loans.

 

Following the closing of the IPO and sale of the Private Placement Units on October 25, 2024 and the exercising of over-allotment option in part on November 19, 2024, a total of $85,212,500 was placed in the trust account, and we had $564,299 of cash held outside of the trust account, after payment of costs related to the IPO, and available for working capital purposes. In connection with the IPO, we incurred $3,408,558 in transaction costs, consisting of $1,275,000 of underwriting fees, $1,700,000 of deferred underwriting fees, $92,195 of the Representative Shares (as discussed below), and $341,363 of other offering costs.

 

In conjunction with the IPO and the exercising of over-allotment option in part, the Company issued to the underwriter 85,000 Class A ordinary shares for no consideration (the “Representative Shares”). The fair value of the Representative Shares accounted for as compensation under the Financial Accounting Standards Board’s Accounting Standards Codification (“ASC”) 718, “Compensation: Stock Compensation” (“ASC 718”) is included in the offering costs. The estimated fair value of the Representative Shares as of the IPO date totaled $92,195.

 

26 

 

 

As of September 30, 2026, the Company had cash of $30,962 and working capital deficit of $2,914,552. The Company expects to incur significant professional costs to remain as a publicly traded company and to incur significant transaction costs in pursuit of the consummation of an initial business combination. In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the unaudited financial statements are issued. Management’s plan in addressing this uncertainty is through the Working Capital Loans, as defined in Note 5 of the financial statements, and the funding of De-SPAC Costs by KQC Quantum, Inc. under Section 5.12 of the Business Combination Agreement, as described in Note 6 of the financial statements. In addition, if the Company is unable to complete an initial business combination by the Combination Deadline, which may be extended month to month to as late as October 25, 2027, the Company’s board of directors would proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company. There is no assurance that the Company’s plans to consummate an initial business combination will be successful within the Combination Deadline. As a result, management has determined that such additional condition also raises substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the unaudited financial statements are issued. The unaudited financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

For the nine months ended September 30, 2026, there was $555,171 of cash used in operating activities resulting from interest and dividend earned on investments held in trust account of $2,435,097, the increase in prepaid expenses of $19,166, and the decrease in due to related parties of $10,927. The changes were offset by net income of $1,405,762, and the increase in accounts payable and accrued expenses of $504,257.

 

For the nine months ended September 30, 2025, there was $436,644 of cash used in operating activities resulting from dividend earned on investments held in trust account of $2,719,802, the increase in prepaid expenses of $27,840, and the decrease in accounts payable and accrued expenses of $17,772. The changes were partially offset by net income of $2,316,270 and the increase in due to related parties of $12,500.

 

For the nine months ended September 30, 2026, there was $1,700,000 of cash used in investing activities resulting from extension fee deposited into trust account of $1,700,000.

 

For the nine months ended September 30, 2025, there were no investing activities.

 

For the nine months ended September 30, 2026, there was $2,280,998 of cash provided by financing activities resulting from proceeds from working capital loan from a related party of $2,280,998, consisting of $1,700,000 of extension loans and $580,998 of loans to fund our working capital needs.

 

For the nine months ended September 30, 2025, there were no financing activities.

 

We intend to use the funds held outside the Trust Account to primarily identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, structure, negotiate and complete an initial business combination.

 

27 

 

 

In order to fund working capital deficiencies or finance transaction costs in connection with an initial business combination, our directors, officers and the sponsor (together, the “insiders”) or their affiliates or designees may, but are not obligated to, loan us funds as may be required. If the Company completes the initial business combination, it would repay such loaned amounts. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from the trust account would be used for such repayment. Up to $3,000,000 of such loans (the “Working Capital Loans”) may be convertible into Units of the Company, at a price of $10.00 per Unit (the “Working Capital Units”) at the option of the lender. As of September 30, 2026 and December 31, 2025, the Company had borrowings of $2,381,879 and $100,881 under the Working Capital Loans, respectively. In addition, under Section 5.12 of the Business Combination Agreement, KQC Quantum, Inc. is responsible for De-SPAC Costs up to $2,500,000, without reimbursement, and on October 26, 2026 the Company requested an advance of $500,000 under that section (see Notes 6 and 9 to the financial statements). As of September 30, 2026, KQC Quantum, Inc. had made no advance to the Company.

 

We believe we will need to raise additional funds in order to meet the expenditures required for operating our business. If our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating an initial business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial business combination. Moreover, we may need to obtain additional financing either to complete our initial business combination or because we become obligated to redeem a significant number of our Public Shares upon completion of our initial business combination in which case we may issue additional securities or incur debt in connection with such initial business combination. In addition, if we are unable to complete an initial business combination by the Combination Deadline, which may be extended month to month to as late as October 25, 2027, the board of directors would proceed to commence a voluntary liquidation and thereby a formal dissolution. There is no assurance that our plans to consummate an initial business combination will be successful within the Combination Deadline. As a result, management has determined that such additional condition also raises substantial doubt about our ability to continue as a going concern.

 

Following the redemptions at the Extension Meeting, $30,597,806 remained in the trust account, compared with the $30,000,000 minimum cash condition in the Business Combination Agreement. Further redemptions in connection with the shareholder vote on the business combination could prevent that condition from being met unless the Company obtains other financing, such as a private placement.

 

Off-Balance Sheet Financing Arrangements

 

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2026. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

 

Contractual Obligations

 

Registration Rights

 

The holders of the founder shares and Private Placement Units, including any Working Capital Units issued upon conversion of Working Capital Loans will be entitled to registration rights pursuant to a registration rights agreement signed on October 24, 2024 by and among the Company and the insiders. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed after the completion of our initial business combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the costs and expenses of filing any such registration statements.

 

28 

 

 

Underwriting Agreement

 

We granted the underwriters a 45-day option from the date of the IPO to purchase up to 1,125,000 additional Public Units to cover over-allotments, if any, at the IPO price less the underwriting discounts and commissions. The underwriters had exercised the over-allotment option in part and purchased 1,000,000 Public Units on November 19, 2024.

 

The underwriters received a cash underwriting discount of $0.15 per Public Unit, or $1,275,000 in the aggregate and paid at the closing of the IPO and the exercising of over-allotment option in part. In addition, the underwriters will be entitled to a deferred fee of $0.20 per Public Unit, or $1,700,000 in the aggregate upon the consummation of an initial business combination. The deferred fee will become payable to the underwriters from the amounts held in the trust account solely in the event that the Company completes its initial business combination, subject to the terms of the underwriting agreement dated October 24, 2024, by and between the Company and Clear Street LLC.

 

Critical Accounting Estimates

 

The preparation of unaudited financial statements in conformity with accounting principles generally accepted in the United States of America (the “US GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. We did not identify any critical accounting estimates.

 

Recent Accounting Pronouncements

 

In November 2024, the FASB issued Accounting Standards Update (“ASU”) 2024-03, “Income Statement, Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses”, requiring public entities to disclose additional information about specific expense categories in the notes to the unaudited financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.

 

Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on our unaudited financial statements.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

 

29 

 

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Quarterly Report, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. Our management evaluated, with the participation of our chief executive officer and chief financial officer (our “Certifying Officers”), the effectiveness of our disclosure controls and procedures as of September 30, 2026, pursuant to Rule 13a-15(b) under the Exchange Act. Based upon that evaluation, our Certifying Officers concluded that, as of September 30, 2026, our disclosure controls and procedures were not effective due to the material weakness in our internal control over financial reporting resulting from inadequate segregation of duties within account processes due to limited personnel and insufficient written policies and procedures for accounting, IT, and financial reporting and record keeping.

 

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

This Quarterly Report does not include an attestation report of internal controls from our independent registered public accounting firm due to our status as an emerging growth company under the JOBS Act.

 

Changes in Internal Control Over Financial Reporting

 

On July 22, 2026, Paul Strickland was appointed Chief Financial Officer, and Jung Min Lee, our Chief Executive Officer, ceased to serve as acting Chief Financial Officer. Other than this change, there were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended September 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

30 

 

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

We are not a party to any material legal proceedings and no material legal proceedings have been threatened by us or, to the best of our knowledge, against us.

 

ITEM 1A. RISK FACTORS

 

As a smaller reporting company, we are not required to include risk factors in this Quarterly Report. However, factors that could cause our actual results to differ materially from those in this Quarterly Report include any of the risks described in our Prospectus, our Annual Report on Form 10-K for the year ended December 31, 2025, and our definitive proxy statement filed with the SEC on October 7, 2026. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. Other than the risk factors set forth in our definitive proxy statement filed with the SEC on October 7, 2026, there have been no material changes to the risk factors disclosed in our Prospectus and our Annual Report on Form 10-K for the year ended December 31, 2025.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

On July 31, 2026, the Company issued an unsecured promissory note in the principal amount of $850,000 to the sponsor (the “Second Extension Note”), and on August 3, 2026, the sponsor deposited $850,000 into the trust account to extend the Combination Deadline from July 25, 2026 to October 25, 2026. On August 25, 2026, the Company issued an unsecured promissory note to the sponsor in the principal amount of up to $500,000 (the “Working Capital Note”). Neither note bears interest, except that overdue amounts accrue default interest at the prevailing short-term U.S. Treasury Bill rate, and each is payable on the earlier of the consummation of the Company’s initial business combination and the Company’s liquidation. At the sponsor’s option, amounts outstanding under each note may be converted into private placement units at $10.00 per unit, each unit consisting of one Class A ordinary share and one right to receive one-eighth of one Class A ordinary share, subject to the $3,000,000 limit on convertible Working Capital Loans. The notes were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act, as transactions by an issuer not involving a public offering.

 

There has been no material change in the planned use of the proceeds from the IPO and the private placements as described in the Prospectus. In October, 2026, $63,157,704 was paid from the trust account to holders of 5,725,962 public shares who redeemed their shares in connection with the Extension Meeting.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

During the quarter ended September 30, 2026, none of our directors or officers adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

 

31 

 

 

ITEM 6. EXHIBITS

 

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report.

 

Exhibit No.   Description
2.1   Business Combination Agreement, dated as of October 6, 2026, by and among the Company, Parent, Merger Sub, and, for the limited purposes specified therein, KQC Korea and the sponsor (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed with the SEC on October 7, 2026)
3.1   Amendment to the Second Amended and Restated Memorandum and Articles of Association of the Company, adopted October 19, 2026 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on October 22, 2026)
10.1   CFO Offer Letter, dated July 22, 2026, between the Company and Paul Strickland (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on July 28, 2026)
10.2   Form of Director Offer Letter (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on July 28, 2026)
10.3   Form of Indemnification Agreement (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the SEC on July 28, 2026)
10.4   Promissory Note, dated July 31, 2026, issued by the Company to the sponsor (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on August 5, 2026)
10.5   Working Capital Note, dated August 25, 2026, issued by the Company to the sponsor (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on August 27, 2026)
10.6   Amendment No. 1 to the Investment Management Trust Agreement, between the Company and Continental Stock Transfer & Trust Company (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on October 22, 2026)
10.7   Promissory Note, dated April 23, 2026, issued by the Company to the sponsor (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on April 27, 2026)
10.8   Promissory Note, dated April 17, 2026, issued by the Company to the sponsor (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on April 27, 2026)
10.9   Sponsor Support Agreement, dated October 6, 2026, by and among the Company, Parent and the Sponsor (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on October 7, 2026)
10.10   Parent Support Agreement, dated October 6, 2026, by and among the Company, Parent and the stockholders of Parent party thereto (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on October 7, 2026)
31.1*   Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*   Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**   Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**   Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*   Inline XBRL Instance Document
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

* Filed herewith.
** Furnished herewith.

 

32 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

CHARLTON ARIA ACQUISITION CORPORATION

 

Date: November 5, 2026 By: /s/ Jung Min Lee
    Jung Min Lee
    Chief Executive Officer
    (Principal Executive Officer)

 

Date: November 5, 2026 By: /s/ Paul Strickland
    Paul Strickland
    Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

33 

Keep reading